There are a lot of bottlenecks throughout clinical trials, which can keep patients from finding or enrolling in the right trials, and keep researchers from sourcing enough eligible patients. Below, we explore the startups looking to disrupt this market and highlight the emerging tech here.
The clinical trials market is ripe for disruption.
From finding the right clinical trials to staying engaged throughout a trial, the patient journey is full of bottlenecks for companies to tackle.
And with over 300,000 clinical trials listed on ClinicalTrials.Gov – the federal database for registered trials — it’s just as difficult for researchers to recruit and retain patients.
For more on this, check out our post on how AI is impacting clinical trials.